Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1968 1
1970 1
1971 1
1972 1
1973 1
1974 2
1975 2
1978 1
1980 2
1981 5
1982 1
1983 1
1985 1
1986 4
1987 2
1989 4
1990 8
1991 6
1992 3
1993 2
1994 4
1996 3
1997 5
1998 4
1999 7
2000 5
2001 7
2002 3
2003 9
2004 8
2005 12
2006 10
2007 6
2008 7
2009 7
2010 6
2011 6
2012 8
2013 10
2014 16
2015 18
2016 11
2017 10
2018 7
2019 6
2020 5
2021 2
2022 6
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

245 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean haren mt (38 results)?
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial.
Ahrén B, Masmiquel L, Kumar H, Sargin M, Karsbøl JD, Jacobsen SH, Chow F. Ahrén B, et al. Lancet Diabetes Endocrinol. 2017 May;5(5):341-354. doi: 10.1016/S2213-8587(17)30092-X. Epub 2017 Apr 3. Lancet Diabetes Endocrinol. 2017. PMID: 28385659 Clinical Trial.
We assessed the efficacy and safety of semaglutide versus the dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin, thiazolidinediones, or both. METHODS: We did a 56-week, phase 3a, randomised, double-bl …
We assessed the efficacy and safety of semaglutide versus the dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin in patients with type 2 d …
Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials.
Ahrén B, Atkin SL, Charpentier G, Warren ML, Wilding JPH, Birch S, Holst AG, Leiter LA. Ahrén B, et al. Diabetes Obes Metab. 2018 Sep;20(9):2210-2219. doi: 10.1111/dom.13353. Epub 2018 Jun 12. Diabetes Obes Metab. 2018. PMID: 29766634 Free PMC article. Clinical Trial.
Semaglutide demonstrated superior reductions in HbA1c and superior weight loss (by 2.3-6.3 kg) versus different comparators across the SUSTAIN 1 to 5 trials; the contributing factors to weight loss are not established. MATERIALS AND METHODS: Subjects with inadequately cont …
Semaglutide demonstrated superior reductions in HbA1c and superior weight loss (by 2.3-6.3 kg) versus different comparators across the SUSTA …
Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion in humans: Characteristics and regulation.
Alsalim W, Lindgren O, Ahrén B. Alsalim W, et al. J Diabetes Investig. 2023 Mar;14(3):354-361. doi: 10.1111/jdi.13962. Epub 2022 Dec 20. J Diabetes Investig. 2023. PMID: 36539382 Free PMC article. Review.
Here, the results of human studies on these novel aspects of meal- and nutrient-stimulated incretin hormone secretion are reviewed. MATERIALS AND METHODS: The human literature was revisited by identifying articles in PubMed using key words GIP, GLP-1, secretion, meal, and …
Here, the results of human studies on these novel aspects of meal- and nutrient-stimulated incretin hormone secretion are reviewed. MATERIAL …
CGG toolkit: Software components for computational genomics.
Vasileiou D, Karapiperis C, Baltsavia I, Chasapi A, Ahrén D, Janssen PJ, Iliopoulos I, Promponas VJ, Enright AJ, Ouzounis CA. Vasileiou D, et al. PLoS Comput Biol. 2023 Nov 7;19(11):e1011498. doi: 10.1371/journal.pcbi.1011498. eCollection 2023 Nov. PLoS Comput Biol. 2023. PMID: 37934729 Free PMC article.
These issues are particularly critical for widely used, efficient, and well-proven methods, especially those developed in research settings that often face funding discontinuities. ...
These issues are particularly critical for widely used, efficient, and well-proven methods, especially those developed in research se …
Effect of Prosthesis-Patient Mismatch on Long-Term Clinical Outcomes After Bioprosthetic Aortic Valve Replacement.
Dismorr M, Glaser N, Franco-Cereceda A, Sartipy U. Dismorr M, et al. J Am Coll Cardiol. 2023 Mar 14;81(10):964-975. doi: 10.1016/j.jacc.2022.12.023. J Am Coll Cardiol. 2023. PMID: 36889875 Free article.
OBJECTIVES: The purpose of this study was to quantify the impact of PPM on all-cause mortality, heart failure hospitalization, and reintervention following bioprosthetic SAVR. METHODS: This observational nationwide cohort study from SWEDEHEART (Swedish Web system for Enhan …
OBJECTIVES: The purpose of this study was to quantify the impact of PPM on all-cause mortality, heart failure hospitalization, and reinterve …
Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans.
Ahrén B, Schweizer A, Dejager S, Villhauer EB, Dunning BE, Foley JE. Ahrén B, et al. Diabetes Obes Metab. 2011 Sep;13(9):775-83. doi: 10.1111/j.1463-1326.2011.01414.x. Diabetes Obes Metab. 2011. PMID: 21507182 Review.
Vildagliptin also inhibits hepatic glucose production, mainly through changes in islet hormone secretion, and improves insulin sensitivity, as determined with a variety of methods. These effects underlie the improved glycaemia with low risk for hypoglycaemia. ...
Vildagliptin also inhibits hepatic glucose production, mainly through changes in islet hormone secretion, and improves insulin sensitivity, …
Research priorities to enhance life for people with spinal cord injury: a Swedish priority setting partnership.
Melin J, Axwalter E, Åhrén G, Sunnerhagen KS, Lundgren-Nilsson Å, Wangdell J. Melin J, et al. Spinal Cord. 2023 Oct;61(10):570-577. doi: 10.1038/s41393-023-00913-2. Epub 2023 Jul 20. Spinal Cord. 2023. PMID: 37474593 Free PMC article. Review.
OBJECTIVE: To identify the top ten research priorities for spinal cord injury (SCI). SETTING: Nationwide in Sweden in 2021-22. METHODS: The PSP process proposed by the James Lind Alliance was used. ...
OBJECTIVE: To identify the top ten research priorities for spinal cord injury (SCI). SETTING: Nationwide in Sweden in 2021-22. METHODS …
Clinical measures of islet function: usefulness to characterize defects in diabetes.
Ahrén B, Pratley RE, Soubt M, Dunning BE, Foley JE. Ahrén B, et al. Curr Diabetes Rev. 2008 May;4(2):129-45. doi: 10.2174/157339908784220714. Curr Diabetes Rev. 2008. PMID: 18473760 Review.
This ability of the pancreatic islets is lost in type 2 diabetes (T2DM). For studies on the pathophysiology of T2DM, methods for analyzing islet function are therefore required. Many methods of varying degrees of complexity have been developed and used to measure pa …
This ability of the pancreatic islets is lost in type 2 diabetes (T2DM). For studies on the pathophysiology of T2DM, methods for anal …
Dermatological moulage collections in the Nordic countries.
Worm AM, Sinisalo H, Eilertsen G, Åhrén E, Meyer I. Worm AM, et al. J Eur Acad Dermatol Venereol. 2018 Apr;32(4):570-580. doi: 10.1111/jdv.14659. Epub 2017 Nov 28. J Eur Acad Dermatol Venereol. 2018. PMID: 29080309
OBJECTIVE: The aim of this study was to elucidate the presence, the origin, the production place, the use and the condition of dermatological moulage collections in the Nordic countries. METHODS: In each Nordic country, an extensive survey was undertaken during spring 2016 …
OBJECTIVE: The aim of this study was to elucidate the presence, the origin, the production place, the use and the condition of dermatologica …
245 results